que es retatrutide Retatrutide—A Game Changer in Obesity Pharmacotherapy GLP-3 RT – True Lab

Your provider will reassess your plan and discuss alternatives

FDA is requesting that the risk be removed from the warnings and precautions section of labeling for the GLP-1 obesity drugs Eli Lilly and Co.s Zepbound (tirzepatide) and Novo Nordisk A/S Saxenda (liraglutide) and Wegovy (semaglutide)

This may present as redness, itching, or irritation at the injection site

Common side effects associated with GLP-1 receptor agonists in published clinical literature include nausea, vomiting, diarrhea, constipation, and abdominal discomfort

Batista AF, Bodart V, De FFG, Ferreira ST

But these options arent as easily removed if at all